Affordable Access

deepdyve-link
Publisher Website

A high-throughput assay of NK cell activity in whole blood and its clinical application.

Authors
  • Lee, Saet-byul1
  • Cha, Junhoe2
  • Kim, Im-kyung3
  • Yoon, Joo Chun4
  • Lee, Hyo Joon1
  • Park, Sang Woo2
  • Cho, Sunjung2
  • Youn, Dong-ye2
  • Lee, Heyja2
  • Lee, Choong Hwan2
  • Lee, Jae Myun1
  • Lee, Kang Young5
  • Kim, Jongsun6
  • 1 Department of Microbiology and Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea. , (North Korea)
  • 2 ATGen Co. Ltd., Sungnam, Republic of Korea. , (North Korea)
  • 3 Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. , (North Korea)
  • 4 Department of Microbiology, Ewha Womans University School of Medicine, Seoul, Republic of Korea. , (North Korea)
  • 5 Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: [email protected] , (North Korea)
  • 6 Department of Microbiology and Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: [email protected] , (North Korea)
Type
Published Article
Journal
Biochemical and Biophysical Research Communications
Publisher
Elsevier
Publication Date
Mar 14, 2014
Volume
445
Issue
3
Pages
584–590
Identifiers
DOI: 10.1016/j.bbrc.2014.02.040
PMID: 24561245
Source
Medline
Keywords
License
Unknown

Abstract

Natural killer (NK) cells are lymphocytes of the innate immune system and have the ability to kill tumor cells and virus-infected cells without prior sensitization. Malignant tumors and viruses have developed, however, strategies to suppress NK cells to escape from their responses. Thus, the evaluation of NK cell activity (NKA) could be invaluable to estimate the status and the outcome of cancers, viral infections, and immune-mediated diseases. Established methods that measure NKA, such as (51)Cr release assay and CD107a degranulation assay, may be used to determine NK cell function, but they are complicated and time-consuming because they require isolation of peripheral blood mononuclear cells (PBMC) or NK cells. In some cases these assays require hazardous material such as radioactive isotopes. To overcome these difficulties, we developed a simple assay that uses whole blood instead of PBMC or isolated NK cells. This novel assay is suitable for high-throughput screening and the monitoring of diseases, because it employs serum of ex vivo stimulated whole blood to detect interferon (IFN)-γ secreted from NK cells as an indicator of NKA. After the stimulation of NK cells, the determination of IFNγ concentration in serum samples by enzyme-linked immunosorbent assay (ELISA) provided a swift, uncomplicated, and high-throughput assay of NKA ex vivo. The NKA results microsatellite stable (MSS) colorectal cancer patients was showed significantly lower NKA, 263.6 ± 54.5 pg/mL compared with healthy subjects, 867.5 ± 50.2 pg/mL (p value <0.0001). Therefore, the NKA could be utilized as a supportive diagnostic marker for microsatellite stable (MSS) colorectal cancer.

Report this publication

Statistics

Seen <100 times